Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 6/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 8/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16905618 | 0.91 | TSHR (0.44) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL21736016 | 0.83 | MAPT (0.40) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL19679641 | 0.83 | MAPT (0.39) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL19246954 | 0.82 | KDM4E (0.40) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL19246888 | 0.82 | KDM4E (0.39) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL20670155 | 0.82 | MAPT (0.38) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL19246887 | 0.82 | TSHR (0.38) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL19246994 | 0.82 | TSHR (0.38) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL18273237 | 0.81 | MAPT (0.47) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 | |
| SCHEMBL19679645 | 0.81 | TSHR (0.37) | ALDH1A1KDM4ELMNAKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160351826-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2016-12-01 | — | — | US | disclosed |
| WO-2015105315-A1 | FUSED-RING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 삼성에스디아이 주식회사 | 2015-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160351826-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALDH1A1 1905/4885KDM4E 3527/4885LMNA 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.